Login to Your Account


Greer Laboratories’ Oralair gets FDA nod in hay fever; $10M to Stallergenes

By Michael Fitzhugh
Staff Writer

Wednesday, April 2, 2014
Hay fever sufferers will have a new option this spring with Wednesday’s FDA approval of Greer Laboratories Inc.’s Oralair, the first under-the-tongue allergen extract approved in the U.S. to treat allergic rhinitis with or without conjunctivitis.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription